June 22-25 | San Diego

Loading

Start-Up Stadium Tuesday Afternoon

June 23, 2026
5B
Loading
  1. Viska Bio is developing targeted extracellular oxidative therapies to convert “cold” tumors into “hot” tumors and enhance immunotherapy. Its proprietary nanobody–enzyme fusion platform combines a VHH ...
    Start-Up Stadium Session
    • Oncology
    5B
  2. Voro Therapeutics is a privately held biotechnology company based in San Diego, spun out of Alloy Therapeutics’ 82VS Venture Studio. The company’s PrimeBody platform is a best-in-class conditionally-a ...
    Start-Up Stadium Session
    • Oncology
    5B
  3. Deck Bio is an emerging biotechnology company focused on expanding the number of patients who can benefit from T cell engagers by overcoming fundamental market access barriers that limit this modality ...
    Start-Up Stadium Session
    • Oncology
    5B
  4. Celliaz Co., Ltd. is a biotechnology company founded in 2022 at KAIST, South Korea, dedicated to developing innovative therapies to restore vision in patients with degenerative retinal diseases. Celli ...
    Start-Up Stadium Session
    • Ophthalmology
    5B
  5. Infixion Bioscience is developing first in class, FDA bound treatments for Neurofibromatosis Type 1 (NF1), a genetic disease affecting 125,000 people in the U.S. and 2.5M worldwide. Founded by NF1 par ...
    Start-Up Stadium Session
    • Orphan and Rare Disease
    5B
  6. AddGraft has reimagined autologous cell therapy by transforming engineered skin cells into living biofactories for durable protein production, enabling local or systemic activity across a variety of i ...
    Start-Up Stadium Session
    • Regenerative Medicine
    5B
  7. Sarcomatrix is a clinical-stage biopharmaceutical company dedicated to redefining the treatment of muscle-wasting diseases through the power of regenerative medicine. Our mission is to develop first-i ...
    Start-Up Stadium Session
    • Regenerative Medicine
    5B
  8. Wink Biotherapeutics is developing novel, RNA-based therapeutics that allow for a functional cure for diabetes. We are the only company in the world that allows for targeted pancreatic beta cell regen ...
    Start-Up Stadium Session
    • Regenerative Medicine
    5B
  9. PAX Therapeutics, having completed IND-enabling studies, is on the cusp of clinical trials to demonstrate optimized tendon healing by the delivery of our growth factor vector which in preclinical stud ...
    Start-Up Stadium Session
    • Regenerative Medicine
    5B

 
Back to Session List

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS

Loading